PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

INTRODUCTION: In vitro evidence suggests that PIK3CA (phosphatidylinositol 3-kinase, catalytic, alpha polypeptide) activation may be associated with altered chemotherapy sensitivity in cancer. METHODS: Tumor DNA from 140 patients with stage II–III breast cancer undergoing neoadjuvant chemotherapy wa...

詳細記述

保存先:
書誌詳細
主要な著者: Liedtke, Cornelia, Cardone, Luca, Tordai, Attila, Yan, Kai, Gomez, Henry L, Figureoa, Luis J Barajas, Hubbard, Rebekah E, Valero, Vicente, Souchon, Eduardo A, Symmans, W Fraser, Hortobagyi, Gabriel N, Bardelli, Alberto, Pusztai, Lajos
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2008
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2397526/
https://ncbi.nlm.nih.gov/pubmed/18371219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1984
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料